Maike Scherf‐Clavel

516 total citations
36 papers, 263 citations indexed

About

Maike Scherf‐Clavel is a scholar working on Psychiatry and Mental health, Pharmacology and Pharmacology. According to data from OpenAlex, Maike Scherf‐Clavel has authored 36 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 14 papers in Pharmacology and 9 papers in Pharmacology. Recurrent topics in Maike Scherf‐Clavel's work include Treatment of Major Depression (13 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Bipolar Disorder and Treatment (8 papers). Maike Scherf‐Clavel is often cited by papers focused on Treatment of Major Depression (13 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Bipolar Disorder and Treatment (8 papers). Maike Scherf‐Clavel collaborates with scholars based in Germany, United States and Ireland. Maike Scherf‐Clavel's co-authors include Stefan Unterecker, Jürgen Deckert, Petra Högger, Andreas Menke, Leif Hommers, Henning Gieseler, Heike Weber, Katharina Domschke, Sarah Kittel‐Schneider and Anne Weidner and has published in prestigious journals such as International Journal of Molecular Sciences, Psychopharmacology and Journal of Pharmaceutical Sciences.

In The Last Decade

Maike Scherf‐Clavel

31 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maike Scherf‐Clavel Germany 11 89 80 40 33 33 36 263
Tonya Quinlan United States 12 183 2.1× 120 1.5× 45 1.1× 14 0.4× 49 1.5× 16 387
Lisbeth Patteet Belgium 11 120 1.3× 88 1.1× 51 1.3× 30 0.9× 41 1.2× 18 425
Louise Karlsson Sweden 14 91 1.0× 40 0.5× 67 1.7× 10 0.3× 49 1.5× 29 601
Rui Peng China 12 33 0.4× 26 0.3× 34 0.8× 68 2.1× 24 0.7× 42 372
Tsung‐Ming Hu Taiwan 12 84 0.9× 32 0.4× 31 0.8× 35 1.1× 10 0.3× 38 422
Takashi Yoshio Japan 10 121 1.4× 101 1.3× 14 0.3× 66 2.0× 21 0.6× 26 405
Jun Miura Japan 10 82 0.9× 69 0.9× 48 1.2× 24 0.7× 186 5.6× 24 399
J Sachse Germany 6 135 1.5× 77 1.0× 38 0.9× 12 0.4× 33 1.0× 9 249
Katrin M. Kirschbaum Germany 13 204 2.3× 80 1.0× 116 2.9× 15 0.5× 79 2.4× 19 511
Eric C Kutscher United States 9 112 1.3× 100 1.3× 20 0.5× 12 0.4× 35 1.1× 19 455

Countries citing papers authored by Maike Scherf‐Clavel

Since Specialization
Citations

This map shows the geographic impact of Maike Scherf‐Clavel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maike Scherf‐Clavel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maike Scherf‐Clavel more than expected).

Fields of papers citing papers by Maike Scherf‐Clavel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maike Scherf‐Clavel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maike Scherf‐Clavel. The network helps show where Maike Scherf‐Clavel may publish in the future.

Co-authorship network of co-authors of Maike Scherf‐Clavel

This figure shows the co-authorship network connecting the top 25 collaborators of Maike Scherf‐Clavel. A scholar is included among the top collaborators of Maike Scherf‐Clavel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maike Scherf‐Clavel. Maike Scherf‐Clavel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scherf‐Clavel, Maike, et al.. (2025). Therapeutic Drug Monitoring of Cariprazine – Updated Values for a Dose-Related Reference Range. Pharmacopsychiatry. 58(3). 127–131. 1 indexed citations
2.
Scherf‐Clavel, Maike, Heike Weber, Leif Hommers, et al.. (2025). CYP1A2 genotype-dependent effects of smoking on mirtazapine serum concentrations. Journal of Psychopharmacology. 39(8). 847–854. 1 indexed citations
3.
Scherf‐Clavel, Maike, et al.. (2025). Physiologically based pharmacokinetic modelling predicts altered maternal pharmacokinetics of amitriptyline during pregnancy. British Journal of Clinical Pharmacology. 91(9). 2636–2648.
4.
Zhang, Aihua, Arun K. Tiwari, Clement C. Zai, et al.. (2025). Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review. Pharmacogenomics. 26(7-9). 295–309.
5.
6.
Unterecker, Stefan, et al.. (2024). Serum Concentration of Antidepressant Drugs in Geriatric Day Care Patients With Renal Insufficiency and Multimorbidity. Therapeutic Drug Monitoring. 47(2). 297–302.
7.
Scherf‐Clavel, Maike, Heike Weber, Stefan Unterecker, Daniel J. Müller, & Jürgen Deckert. (2024). Frequencies of CYP2C19 and CYP2D6 gene variants in a German inpatient sample with mood and anxiety disorders. The World Journal of Biological Psychiatry. 25(4). 214–221.
8.
Taurines, Regina, Jörg M. Fegert, Christoph Wewetzer, et al.. (2024). Serum Concentration–Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine. Pharmaceutics. 16(6). 772–772.
9.
Hiemke, Christoph, Ursula Havemann‐Reinecke, Gudrun Hefner, et al.. (2023). Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis. Psychopharmacology. 241(2). 275–289. 8 indexed citations
10.
Scherf‐Clavel, Maike, Andreas Eckert, Heike Weber, et al.. (2023). Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study. International Journal of Clinical Pharmacy. 45(5). 1107–1117. 8 indexed citations
11.
Scherf‐Clavel, Maike, Pierre Baumann, Heike Schneider, et al.. (2023). Behind the Curtain: Therapeutic Drug Monitoring of Psychotropic Drugs from a Laboratory Analytical Perspective. Therapeutic Drug Monitoring. 46(2). 143–154. 8 indexed citations
12.
Scherf‐Clavel, Maike, et al.. (2023). Recommendation for a Therapeutic Reference Range of Cariprazine—A Short Communication. Therapeutic Drug Monitoring. 46(2). 270–273. 1 indexed citations
13.
Scherf‐Clavel, Maike, et al.. (2022). Psychotropic medication in pregnancy and lactation and early development of exposed children. British Journal of Clinical Pharmacology. 89(2). 737–750. 10 indexed citations
14.
Hommers, Leif, Maike Scherf‐Clavel, Julian Roth, et al.. (2021). Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age. Journal of Psychopharmacology. 35(9). 1127–1133. 12 indexed citations
15.
Scherf‐Clavel, Maike, Leif Hommers, Jürgen Deckert, et al.. (2020). Higher venlafaxine serum concentrations necessary for clinical improvement? Time to re-evaluate the therapeutic reference range of venlafaxine. Journal of Psychopharmacology. 34(10). 1105–1111. 11 indexed citations
16.
Scherf‐Clavel, Maike, Felix Nitschké, Stefan Unterecker, et al.. (2020). Extent of cortisol suppression at baseline predicts improvement in HPA axis function during antidepressant treatment. Psychoneuroendocrinology. 114. 104590–104590. 9 indexed citations
17.
Scherf‐Clavel, Maike, et al.. (2019). Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients. European Journal of Clinical Pharmacology. 76(1). 73–80. 2 indexed citations
18.
Scherf‐Clavel, Maike, et al.. (2019). Determination of hydroxybupropion in human serum for routine therapeutic drug monitoring in psychiatry: A tool for dose‐individualization in treatment with bupropion. Biomedical Chromatography. 33(10). e4609–e4609. 4 indexed citations
19.
Scherf‐Clavel, Maike, et al.. (2019). Analysis of smoking behavior on the pharmacokinetics of antidepressants and antipsychotics. International Clinical Psychopharmacology. 34(2). 93–100. 23 indexed citations
20.
Scherf‐Clavel, Maike & Petra Högger. (2015). Analysis of metformin, sitagliptin and creatinine in human dried blood spots. Journal of Chromatography B. 997. 218–228. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tonya Quinlan Breakdown of academic impact, for papers by Lisbeth Patteet Breakdown of academic impact, for papers by Louise Karlsson Breakdown of academic impact, for papers by Rui Peng Breakdown of academic impact, for papers by Tsung‐Ming Hu Breakdown of academic impact, for papers by Takashi Yoshio Breakdown of academic impact, for papers by Jun Miura Breakdown of academic impact, for papers by J Sachse Breakdown of academic impact, for papers by Katrin M. Kirschbaum Breakdown of academic impact, for papers by Eric C Kutscher
Rankless by CCL
2026